Biller Jonathan
EVP and Chief Legal Officer · 17 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 945 | $486.35 | $459,600.75 | filing |
| 2026-02-24 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,144 | $485.11 | $554,965.84 | filing |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,244 | $473.68 | $589,257.92 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,476 | $489.46 | $1.2M | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,505 | $483.75 | $728,043.75 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 4,135 | $0.00 | $0.00 | filing |
| 2026-02-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 2,993 | $487.76 | $1.5M | filing |
| 2026-02-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 988 | $499.00 | $493,012.00 | filing |
| 2026-02-11 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,925 | $460.43 | $886,327.75 | filing |
| 2026-02-11 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,925 | $460.43 | $886,327.75 | filing |
| 2026-02-10 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,630 | $468.41 | $763,508.30 | filing |
| 2026-02-10 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,630 | $468.41 | $763,508.30 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 6,294 | $0.00 | $0.00 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 2,774 | $0.00 | $0.00 | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 347 | $449.00 | $155,803.00 | filing |
| 2025-10-02 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 694 | $404.21 | $280,521.74 | filing |
| 2025-10-01 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,259 | $400.00 | $503,600.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.